β³ Fetching live dividend data...
Home βΊ Calculator βΊ TFX Dividend Calculator 2026
Teleflex Incorporated Β· NYSE
Price: $134.32 Β· Annual div: $1.36/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in TFX β $1.9K in 10 years Β· $10.27/month
Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open TFX position with:
Real after-tax yield depends on where you live and how you hold TFX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 1.01% | -1.79% | $101 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 0.86% | -1.94% | $86 / yr |
| πΊπΈ US Taxable (20%) | 20% | 0.81% | -1.99% | $81 / yr |
| π¬π§ UK ISA | 0% | 1.01% | -1.79% | $101 / yr |
| π¬π§ UK Taxable | 8.75% | 0.92% | -1.88% | $92 / yr |
| π¨π¦ TFSA | 0% | 1.01% | -1.79% | $101 / yr |
| π¨π¦ CA Taxable | 25% | 0.76% | -2.04% | $76 / yr |
| π¦πΊ Super (pension) | 15% | 0.86% | -1.94% | $86 / yr |
| π¦πΊ AU Taxable | 30% | 0.71% | -2.09% | $71 / yr |
| π©πͺ DE Taxable | 26.375% | 0.74% | -2.06% | $74 / yr |
| π«π· FR Taxable | 30% | 0.71% | -2.09% | $71 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.36/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
TFX pays quarterly β 4 times per year. Next ex-div: TBD.
How TFX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for TFX sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-08 | 4,663 | β | β | ||
| A-Award | 2026-06-08 | 995 | β | β | ||
| F-InKind | 2026-06-07 | 4,054 | $129.84 | $526.4K | ||
| A-Award | 2026-06-08 | 2,192 | $131.74 | $288.8K | ||
| A-Award | 2026-06-08 | 53,983 | β | β | ||
| A-Award | 2026-06-08 | 26,071 | $131.74 | $3.43M | ||
| A-Award | 2026-05-15 | 1,090 | β | β | ||
| A-Award | 2026-05-15 | 2,397 | $129.71 | $310.9K | ||
| A-Award | 2026-05-15 | 1,090 | β | β | ||
| A-Award | 2026-05-15 | 2,397 | $129.71 | $310.9K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the TFX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Teleflex Incorporated (TFX) is currently trading at $134.32, 68% below its 52-week high. The current dividend yield is 1.01% based on an annual payout of $1.36 per share.
Teleflex Incorporated (TFX) is a healthcare stock currently trading at $134.32 with a dividend yield of 1.01%. The company pays an annual dividend of $1.36 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, TFX has grown its dividend at a compound annual rate of 0.7%.
Auto-generated from live market data. For educational purposes only β not financial advice.
News aggregated from public sources via Finnhub & RSS. For informational purposes only.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β